Straub; Christopher Sean
Patent Applications and Registrations
Patent applications and USPTO patent grants for Straub; Christopher Sean.The latest application filed is for "smac peptidometics useful as iap inhibitors".
- Straub; Christopher Sean - Stow MA
- Straub; Christopher Sean - Cambridge MA
| Patent | Date |
|---|---|
| Dimeric IAP inhibitors Grant 8,993,523 - Chen , et al. March 31, 2 | 2015-03-31 |
| Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}- -2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof Grant 8,906,936 - Jensen , et al. December 9, 2 | 2014-12-09 |
| Smac Peptidometics Useful As Iap Inhibitors App 20140004101 - Chen; Zhuoliang ; et al. | 2014-01-02 |
| Dimeric Iap Inhibitors App 20130309247 - Chen; Zhuoliang ; et al. | 2013-11-21 |
| Dimeric Iap Inhibitors App 20130266590 - Straub; Christopher Sean ; et al. | 2013-10-10 |
| (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrro- lidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses Grant 8,552,003 - Charest , et al. October 8, 2 | 2013-10-08 |
| SMAC peptidometics useful as IAP inhibitors Grant 8,546,336 - Chen , et al. October 1, 2 | 2013-10-01 |
| Combination of Organic Compounds App 20130217719 - Jensen; Michael Rugaard ; et al. | 2013-08-22 |
| Combination Of An Iap Inhibitor And A Taxane For The Treatment Of A Proliferative Disease App 20130085153 - Jensen; Michael Rugaard ; et al. | 2013-04-04 |
| Smac Peptidometics Useful As Iap Inhibitors App 20130005663 - CHAREST; Mark G. ; et al. | 2013-01-03 |
| Inhibitors of IAP Grant 8,338,440 - Palermo , et al. December 25, 2 | 2012-12-25 |
| Inhibitors of IAP Grant 8,207,183 - Palermo , et al. June 26, 2 | 2012-06-26 |
| Organic Compounds App 20110319614 - CHEN; Zhuoliang ; et al. | 2011-12-29 |
| Organic compounds Grant 8,058,272 - Chen , et al. November 15, 2 | 2011-11-15 |
| Substituted pyrazine-3-one-derivatives as IAP inhibitors Grant 8,048,886 - Chen , et al. November 1, 2 | 2011-11-01 |
| Pyrrolydine derivatives as IAP inhibitors Grant 8,044,209 - Charest , et al. October 25, 2 | 2011-10-25 |
| Dimeric Iap Inhibitors App 20110206690 - STRAUB; Christopher Sean ; et al. | 2011-08-25 |
| Combinations of Organic Compounds App 20100324083 - JENSEN; Michael Rugaard ; et al. | 2010-12-23 |
| Organic Compounds App 20100316573 - Gaither; Larry Alexander ; et al. | 2010-12-16 |
| Organic Compounds App 20100249405 - Chen; Zhuoliang ; et al. | 2010-09-30 |
| Organic Compounds App 20100048571 - Chen; Zhuoliang ; et al. | 2010-02-25 |
| Combinations of Organic Compounds App 20090005411 - Jensen; Michael Rugaard ; et al. | 2009-01-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 